{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T03:16:45Z","timestamp":1777951005076,"version":"3.51.4"},"reference-count":27,"publisher":"PeerJ","license":[{"start":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T00:00:00Z","timestamp":1777852800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>High-sensitivity C-reactive protein (hs-CRP) has emerged as a significant biomarker for assessing inflammatory activity in atherosclerosis, which may predict sudden death, especially in individuals with advanced atherosclerotic disease or those at high risk for acute events.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This systematic review aimed to evaluate the significance of changes in hs-CRP levels over time in the population with atherosclerosis; the frequency of cardiovascular events, including mortality, stroke, and myocardial infarction; and changes in the progression of atherosclerosis. We conducted a comprehensive search of the PubMed, Scopus, Web of Science, and Embase databases up to January 2026 to identify observational and cohort studies evaluating high hs-CRP levels in patients with atherosclerosis, and to evaluate the quality of studies using the Newcastle-Ottawa Scale (NOS).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Our results included six studies involving baseline and follow-up hs-CRP values that showed a relationship between elevated baseline hs-CRP levels and an increased incidence of atherosclerotic progression that led to cardiovascular events. In addition, the variability in inflammation severity across different clinical events was displayed by the range of baseline hs-CRP measurements across different patient groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Universal screening for hs-CRP may improve assessment and thereby reduce the risk of cardiovascular events.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.7717\/peerj.21217","type":"journal-article","created":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T08:43:17Z","timestamp":1777884197000},"page":"e21217","source":"Crossref","is-referenced-by-count":0,"title":["Hs-CRP as a biomarker for atherosclerosis progression and cardiovascular risk: a systematic review"],"prefix":"10.7717","volume":"14","author":[{"given":"Dalal A.","family":"Al-Saedi","sequence":"first","affiliation":[{"name":"Department of Chemistry, College of Science, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kholoud M.","family":"Al-Otaibi","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Faculty of Science, Al-Baha University, Al-Baha, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Alalhareth","sequence":"additional","affiliation":[{"name":"Najran Health Cluster, Najran, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"Aldurayhim","sequence":"additional","affiliation":[{"name":"Department of Laboratory, Prince Sultan Military Medical City, Riyadh, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdulmajeed","family":"Alomari","sequence":"additional","affiliation":[{"name":"Al Kharj Military Industries Corporation Hospital, Alkharj, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bushra","family":"Aljadani","sequence":"additional","affiliation":[{"name":"Al-Ghad International Health Sciences Colleges, Jeddah, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jumana J.","family":"Siddiqui","sequence":"additional","affiliation":[{"name":"Department of Laboratory, International Medical Center, Jeddah, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fadi","family":"Alawaji","sequence":"additional","affiliation":[{"name":"Qassim Health Cluster, Qassim, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nourh T.","family":"Almotiry","sequence":"additional","affiliation":[{"name":"National Guard health affairs, Riyadh, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdurahman","family":"Alloghbi","sequence":"additional","affiliation":[{"name":"Department of Oncology, King Khalid University, Abha, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4443","published-online":{"date-parts":[[2026,5,4]]},"reference":[{"key":"10.7717\/peerj.21217\/ref-1","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1001\/archinternmed.2012.3712","article-title":"Within-person variability in high-sensitivity C-reactive protein","volume":"172","author":"Bower","year":"2012","journal-title":"Archives of Internal Medicine"},{"key":"10.7717\/peerj.21217\/ref-2","doi-asserted-by":"publisher","first-page":"e012638","DOI":"10.1161\/JAHA.119.012638","article-title":"hsCRP level and the risk of death or recurrent cardiovascular events in patients with myocardial infarction: a healthcare-based study","volume":"8","author":"Carrero","year":"2019","journal-title":"Journal of the American Heart Association"},{"key":"10.7717\/peerj.21217\/ref-3","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1056\/NEJMoa032804","article-title":"C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease","volume":"350","author":"Danesh","year":"2004","journal-title":"The New England Journal of Medicine"},{"key":"10.7717\/peerj.21217\/ref-4","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.ijcard.2023.03.043","article-title":"History of peripheral artery disease and cardiovascular risk of real-world patients with acute coronary syndrome: role of inflammation and comorbidities","volume":"382","author":"Denegri","year":"2023","journal-title":"International Journal of Cardiology"},{"key":"10.7717\/peerj.21217\/ref-5","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1177\/0003319712441855","article-title":"Changes in small dense low-density lipoprotein levels following acute coronary syndrome","volume":"64","author":"Emadzadeh","year":"2013","journal-title":"Angiology"},{"key":"10.7717\/peerj.21217\/ref-6","doi-asserted-by":"publisher","first-page":"4356","DOI":"10.1097\/MS9.0000000000003455","article-title":"The relation between C-reactive protein (CRP) and risk of incident heart failure in patients with cardiovascular disease: a narrative review","volume":"87","author":"Fatima","year":"2025","journal-title":"Annals of Medicine and Surgery"},{"key":"10.7717\/peerj.21217\/ref-7","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1159\/000365185","article-title":"Atherosclerotic plaque morphology indicates clinical symptoms of plaque progression","volume":"129","author":"Feng","year":"2014","journal-title":"Cardiology"},{"key":"10.7717\/peerj.21217\/ref-8","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.athplu.2024.09.004","article-title":"Lipoprotein(a) and the atherosclerotic burden\u2014should we wait for clinical trial evidence before taking action?","volume":"58","author":"Fichtner","year":"2024","journal-title":"Atherosclerosis Plus"},{"key":"10.7717\/peerj.21217\/ref-9","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s12944-024-02055-7","article-title":"The predictive value of the hs-CRP\/HDL-C ratio, an inflammation-lipid composite marker, for cardiovascular disease in middle-aged and elderly people: evidence from a large national cohort study","volume":"23","author":"Gao","year":"2024","journal-title":"Lipids in Health and Disease"},{"key":"10.7717\/peerj.21217\/ref-10","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1159\/000540773","article-title":"Intra-individual reproducibility of early and late C-reactive protein and interleukin-6 in patients with non-severe ischaemic stroke and carotid atherosclerosis","volume":"15","author":"Gorey","year":"2025","journal-title":"Cerebrovascular Diseases Extra"},{"key":"10.7717\/peerj.21217\/ref-11","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1161\/hc2601.091705","article-title":"C-Reactive protein is an independent predictor of the rate of increase in early carotid atherosclerosis","volume":"104","author":"Hashimoto","year":"2001","journal-title":"Circulation"},{"key":"10.7717\/peerj.21217\/ref-12","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1007\/s00059-004-2577-1","article-title":"Time-dependent changes of hs-CRP serum concentration in patients with non-ST elevation acute coronary syndrome","volume":"29","author":"Jahn","year":"2004","journal-title":"Herz"},{"key":"10.7717\/peerj.21217\/ref-13","doi-asserted-by":"publisher","first-page":"25","DOI":"10.21542\/gcsp.2018.25","article-title":"Hypertrophic cardiomyopathy: sudden cardiac death risk stratification in adults","volume":"2018","author":"Jord\u00e0","year":"2018","journal-title":"Global Cardiology Science & Practice"},{"key":"10.7717\/peerj.21217\/ref-14","doi-asserted-by":"publisher","first-page":"297","DOI":"10.31083\/j.rcm2410297","article-title":"C-reactive protein in atherosclerosis\u2014more than a biomarker, but not just a culprit","volume":"24","author":"Kirkgoz","year":"2023","journal-title":"Reviews in Cardiovascular Medicine"},{"key":"10.7717\/peerj.21217\/ref-15","first-page":"42","article-title":"Variation in high-sensitivity C-reactive protein levels over 24 h in patients with stable coronary artery disease","volume":"37","author":"Koc","year":"2010","journal-title":"Texas Heart Institute Journal"},{"key":"10.7717\/peerj.21217\/ref-16","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/j.amjcard.2009.01.029","article-title":"Incidence, predictors, and outcome of new, subsequent lesions treated with percutaneous coronary intervention in patients presenting with myocardial infarction","volume":"103","author":"Lemesle","year":"2009","journal-title":"The American Journal of Cardiology"},{"key":"10.7717\/peerj.21217\/ref-17","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.7717\/peerj.21217\/ref-18","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1097\/01.OGX.0000058687.18516.14","article-title":"Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events","volume":"58","author":"Ridker","year":"2003","journal-title":"Obstetrical & Gynecological Survey"},{"key":"10.7717\/peerj.21217\/ref-19","doi-asserted-by":"publisher","first-page":"51","DOI":"10.32734\/idjpcr.v3i1.4015","article-title":"The role of hs-CRP in predicting the likelihood of coronary heart disease","volume":"3","author":"Sitepu","year":"2020","journal-title":"Indonesian Journal of Pharmaceutical and Clinical Research"},{"key":"10.7717\/peerj.21217\/ref-20","doi-asserted-by":"publisher","first-page":"3887","DOI":"10.3889\/oamjms.2019.526","article-title":"Atherosclerosis prediction with high sensitivity C-reactive protein (hs-CRP) and related risk factor in patient with dyslipidemia","volume":"7","author":"Swastini","year":"2019","journal-title":"Open Access Macedonian Journal of Medical Sciences"},{"key":"10.7717\/peerj.21217\/ref-21","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1016\/j.jacc.2018.08.1038","article-title":"Fourth universal definition of myocardial infarction (2018)","volume":"72","author":"Thygesen","year":"2018","journal-title":"Journal of the American College of Cardiology"},{"key":"10.7717\/peerj.21217\/ref-22","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.jcmg.2017.08.013","article-title":"Colchicine therapy and plaque stabilization in patients with acute coronary syndrome","volume":"11","author":"Vaidya","year":"2018","journal-title":"JACC: Cardiovascular Imaging"},{"key":"10.7717\/peerj.21217\/ref-23","doi-asserted-by":"publisher","first-page":"e139\u2013e596","DOI":"10.1161\/CIR.0000000000000757","article-title":"Heart disease and stroke statistics\u20142020 update: a report from the American Heart Association","volume":"141","author":"Virani","year":"2020","journal-title":"Circulation"},{"key":"10.7717\/peerj.21217\/ref-24","article-title":"The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses","author":"Wells","year":"2011"},{"key":"10.7717\/peerj.21217\/ref-25","doi-asserted-by":"publisher","first-page":"108165","DOI":"10.1016\/j.pharmthera.2022.108165","article-title":"Transitional changes in the structure of C-reactive protein create highly pro-inflammatory molecules: therapeutic implications for cardiovascular diseases","volume":"235","author":"Zeller","year":"2022","journal-title":"Pharmacology & Therapeutics"},{"key":"10.7717\/peerj.21217\/ref-26","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/j.jacc.2021.07.016","article-title":"High-sensitivity C-reactive protein modifies the cardiovascular risk of Lipoprotein(a)","volume":"78","author":"Zhang","year":"2021","journal-title":"Journal of the American College of Cardiology"},{"key":"10.7717\/peerj.21217\/ref-27","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.3892\/mmr.2019.10382","article-title":"NLRP3 inflammasome expression in peripheral blood monocytes of coronary heart disease patients and its modulation by rosuvastatin","volume":"20","author":"Zhu","year":"2019","journal-title":"Molecular Medicine Reports"}],"container-title":["PeerJ"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/peerj.com\/articles\/21217.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/peerj.com\/articles\/21217.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/peerj.com\/articles\/21217.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/peerj.com\/articles\/21217.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T08:43:18Z","timestamp":1777884198000},"score":1,"resource":{"primary":{"URL":"https:\/\/peerj.com\/articles\/21217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,4]]},"references-count":27,"alternative-id":["10.7717\/peerj.21217"],"URL":"https:\/\/doi.org\/10.7717\/peerj.21217","archive":["CLOCKSS","LOCKSS","Portico"],"relation":{},"ISSN":["2167-8359"],"issn-type":[{"value":"2167-8359","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,4]]},"article-number":"e21217"}}